About Pharmacyclics
Pharmacyclics is a Healthcare company based in Sunnyvale (United States) founded in 1991, and was acquired by AbbVie in March 2015. Small-molecule drugs for cancer and immune diseases are developed. It operates on a HealthTech model. Pharmacyclics offers products and services including Cancer Treatments and Immune-Mediated Disease Therapies. Its focus areas include Pharmaceuticals and Oncology. Its legal entity is Pharmacyclics LLC. Its competitors include Moderna, BeiGene and Incyte; 2 of its 3 listed competitors have raised funding.
Company details
Pharmacyclics, an AbbVie company, is dedicated to the development of safe and effective treatment options for individuals affected by cancer and immune-mediated diseases. Based in the Bay Area, California, the company operates within the healthcare sector, specifically targeting oncology and related therapeutic areas. Solutions are crafted to help patients and families regain a sense of normalcy, with the mission of ensuring that disease no longer dominates daily life.
- Headquarters Sunnyvale, United States
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website pharmacyclics.com
- Social LinkedIn X Facebook
- Acquired by AbbVie (Mar 2015)
- Legal Name Pharmacyclics Llc
Products & Services of Pharmacyclics
Pharmacyclics offers a comprehensive portfolio of products and services, including Cancer Treatments and Immune-Mediated Disease Therapies.
Treatments for cancer are developed and provided by Pharmacyclics.
Therapies for immune-mediated diseases are offered by the company.
Funding Insights of Pharmacyclics
- Total Rounds 4
- Last Round Debt – Venture — $50M
- Investors Count 2
All 4 funding rounds of Pharmacyclics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2012 | $50M | Debt – Venture | – | – | |
| Feb 2009 | $1.4M | Post-IPO | – | – | – |
| Jan 2009 | $5M | Debt – Venture | – | – | – |
| Jun 1991 | Series A | – | – |
3 investors in total: 3 institutional.
Investors in Pharmacyclics
Pharmacyclics has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include AbbVie, Johnson & Johnson Innovative Medicine and Venrock.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on tech sectors | venrock.com | Palo Alto, United States | ||
Diversified drugs are manufactured for various therapeutic areas. | 1953 | janssen.com | Raritan, United States | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | abbvie.com | Chicago, United States |
Investor details for Pharmacyclics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Pharmacyclics
7 people are tracked at Pharmacyclics (4 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Wulff-Erik von Borcke | President | Leadership |
Rafael Dugarte | Head Of Finance | Leadership |
Jutta K. Neuenburg | Medical Director | Leadership |
Anita Szoke M.D. | Medical Director | Leadership |
Clare W. | Financial Controller | Team |
Debbie Pierre | Supervisor - Financial Planning & Analysis R&d | Team |
Patty Tan | Executive Assistant | Team |
Complete people profiles for Pharmacyclics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Pharmacyclics
4 dated milestones of Pharmacyclics across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Pharmacyclics is founded.
- Funding First funding round.
- Funding Latest funding round, Debt – Venture, of $50.0M.
- Exit Acquired by AbbVie.
Competitors of Pharmacyclics
Pharmacyclics has 3 listed competitors in our database, 2 of them funded. They include Moderna, BeiGene and Incyte.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| modernatx.com | 2010 | Cambridge, United States | $2.78B | 1,312 | mRNA-based therapeutics for diseases including cancer and infections are developed. | |
| beigene.com | 2010 | Cambridge, United States | $172M | 1,090 | Targeted and immune-oncology drugs for cancer treatment are developed. | |
| incyte.com | 1991 | Wilmington, United States | 1,387 | Small molecules are developed for cancer and skin disease treatments. |
Detailed competitors of Pharmacyclics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Pharmacyclics
The website of Pharmacyclics (pharmacyclics.com) receives about 3.1K visits a month and ranks #5,482,945 among all websites worldwide, #6,098 in Biotechnology and Pharmaceuticals.
- Monthly visits3.1K
▲ 5.8% vs previous month
- Unique visitors1.2K
per month
- Global rank#5,482,945
among all websites
- Category rank#6,098
Health · Biotechnology and Pharmaceuticals
- Bounce rate37%
- Pages per visit1.9
- Average visit32 sec
- DevicesDesktop 26% · Mobile 74%
Websites whose visitors overlap most with Pharmacyclics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| seattlegenetics.com | 100% | View details | |||
| medivation.com | 92% | View details | |||
| sunesis.com | 80% | View details | |||
| pfizer.com | 79% | 1.9M | #24,984 | View details | |
| novartis.com | 74% | 948.8K | #58,822 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for Pharmacyclics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Oncology
3 companies that operate in the same segment as Pharmacyclics (Oncology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pharmacyclics
Complete news archive for Pharmacyclics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharmacyclics
Pharmacyclics was founded in 1991.
Pharmacyclics is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Annual revenue of Pharmacyclics is $729.73M as on Dec 31, 2014.
Pharmacyclics, an AbbVie company, is dedicated to the development of safe and effective treatment options for individuals affected by cancer and immune-mediated diseases. Based in the Bay Area, California, the company operates within the healthcare sector, specifically targeting oncology and related therapeutic areas. Solutions are crafted to help patients and families regain a sense of normalcy, with the mission of ensuring that disease no longer dominates daily life.
Pharmacyclics offers Cancer Treatments and Immune-Mediated Disease Therapies.
Pharmacyclics has 3 investors. Key investors include AbbVie, Johnson & Johnson Innovative Medicine, and Venrock.
Pharmacyclics operates through Pharmacyclics Llc.
Yes. Pharmacyclics was acquired by AbbVie in March 2015.